Literature DB >> 16275191

Effect of atrial fibrillation pattern on survival in a community-based cohort.

Richard J Keating1, Bernard J Gersh, David O Hodge, Peggy L Weivoda, Philip J Patel, Stephen C Hammill, Win-Kuang Shen.   

Abstract

The clinical presentation of recurrent atrial fibrillation (AF) has been categorized into 3 general patterns: paroxysmal, persistent, and permanent AF. This community-based cohort study characterized the effect of the AF pattern on survival. Community residents in Olmsted County, Minnesota, with electrocardiographically proven new-onset AF during 1996 and 1997 were retrospectively identified and prospectively followed. Observed survival was estimated using the Kaplan-Meier method and compared with the expected survival. Log-rank tests were used for group comparisons. The association between the baseline variables and mortality was assessed using Cox proportional hazards models. Of 270 patients (mean +/- SD age 73 +/- 14 years; 148 men [55%]), 143 had paroxysmal AF, 40 had persistent AF, and 87 had permanent AF. The cohort's observed survival was significantly worse than expected (p <0.001). The factors associated with increased mortality included older age, concomitant heart failure, and concomitant chronic obstructive pulmonary disease (all p <0.001). Permanent AF was associated with higher mortality than paroxysmal AF (hazard ratio 1.6, 95% confidence interval 1.1 to 2.3). Persistent AF was associated with better survival (hazard ratio 0.3, 95% confidence interval 0.1 to 0.8). In conclusion, survival among patients with persistent AF was significantly better than that among patients with paroxysmal AF or permanent AF. The ability to maintain sinus rhythm may be associated with better survival.

Entities:  

Mesh:

Year:  2005        PMID: 16275191     DOI: 10.1016/j.amjcard.2005.07.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  [Atrial fibrillation].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

2.  Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.

Authors:  David Conen; Claudia U Chae; Robert J Glynn; Usha B Tedrow; Brendan M Everett; Julie E Buring; Christine M Albert
Journal:  JAMA       Date:  2011-05-25       Impact factor: 56.272

Review 3.  Challenges in the classification of atrial fibrillation.

Authors:  Steven A Lubitz; Emelia J Benjamin; Jeremy N Ruskin; Valentin Fuster; Patrick T Ellinor
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 4.  Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management.

Authors:  T Ben Morrison; T Jared Bunch; Bernard J Gersh
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-02

Review 5.  Status of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

Review 6.  How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Authors:  Rajiv Sankaranarayanan; Graeme Kirkwood; Rajaverma Visweswariah; David J Fox
Journal:  Curr Cardiol Rev       Date:  2015

7.  Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community.

Authors:  Steven A Lubitz; Carlee Moser; Lisa Sullivan; Michiel Rienstra; João D Fontes; Mark L Villalon; Manju Pai; David D McManus; Renate B Schnabel; Jared W Magnani; Xiaoyan Yin; Daniel Levy; Michael J Pencina; Martin G Larson; Patrick T Ellinor; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-09-03       Impact factor: 5.501

8.  The progression in atrial fibrillation patients with COPD: a systematic review and meta-analysis.

Authors:  Xiaoying Chen; Meiling Lin; Wei Wang
Journal:  Oncotarget       Date:  2017-10-26

9.  Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study.

Authors:  Maria A Shkolnikova; Dmitri A Jdanov; Rukizhat A Ildarova; Natalia V Shcherbakova; Ekaterina B Polyakova; Evgeny N Mikhaylov; Svetlana A Shalnova; Vladimir M Shkolnikov
Journal:  J Geriatr Cardiol       Date:  2020-02       Impact factor: 3.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.